Patents by Inventor Bruce Tallion

Bruce Tallion has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • WNT-regulated cytokine-like polypeptide and nucleic acids encoding same
    Patent number: 7566536
    Abstract: The present invention provides novel polypeptides, termed FCTRX polypeptides, as well as polynucleotides encoding FCTRX polypeptides and antibodies that immunospecifically bind to an FCTRX or a derivative, variant, mutant, or fragment of an FCTRX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the FCTRX polypeptide, polynucleotide and antibody are used in detection and treatment of a broad range of pathological states, as well as to other uses.
    Type: Grant
    Filed: July 7, 2003
    Date of Patent: July 28, 2009
    Assignees: CuraGen Corporation, Genentech, Inc.
    Inventors: David P. Andrew, David A. Lewin, Diane Pennica, Luca Rastelli, Bruce Tallion
  • WNT-regulated cytokine-like polypeptide and nucleic acids encoding same
    Publication number: 20050250178
    Abstract: The present invention provides novel polypeptides, termed FCTRX polypeptides, as well as polynucleotides encoding FCTRX polypeptides and antibodies that immunospecifically bind to an FCTRX or a derivative, variant, mutant, or fragment of an FCTRX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the FCTRX polypeptide, polynucleotide and antibody are used in detection and treatment of a broad range of pathological states, as well as to other uses.
    Type: Application
    Filed: July 7, 2003
    Publication date: November 10, 2005
    Inventors: David Andrew, David Lewin, Diane Pennica, Luca Rastelli, Bruce Tallion